The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
In the issue brief, KFF experts highlight the laws and regulations that are in place to ensure access to free COVID-19 vaccines for individuals regardless of their insurance status and explain how vaccine administration costs will be covered in private insurance, Medicare and Medicaid, and for the uninsured.
This brief answers key questions about the U.S. monkeypox outbreak to date and identifies issues that may affect the response going forward.
This analysis examines monkeypox vaccine allocations and jurisdictional requests. It explores jurisdictional request rate (the number of vaccine does requested as a share of the jurisdiction’s allocation from HHS) for JYNNEOS, the preferred vaccine. Overall, while most jurisdictions have requested at least their full supply, some are well below that mark, raising questions about how quickly their at-risk populations can get protected.
Adults who report having ever been told by a doctor they have a weakened or compromised immune system are more likely than others to say they are worried about serious COVID-19 illness, with many reporting continued mask wearing and other precautions as mask mandates and other pandemic-relate restrictions are lifted.
A small number of states, as well as some local jurisdictions, are reporting race/ethnicity data on MPX cases and vaccinations and these data show a disproportionate impact of MPX cases on Black and Hispanic people. The data available to date on vaccinations also suggest that Black and Hispanic people are receiving smaller shares of vaccinations despite accounting for larger shares of cases.
This fact sheet offers a look back at 10 issues that KFF tracked closely during 2023 in its polling, policy analysis and journalism, including summaries of major findings and news stories.
In this issue, we take a closer look at the reliability of artificial intelligence (AI) chatbots as a source of health information. We explore public opinion on chatbot accuracy based on KFF surveys and highlight recent examples of AI-generated election misinformation in the news. In addition, we share our firsthand experience querying AI chatbots on health topics and discuss research on gaps in safeguards.
As rates of childhood vaccination decline and with measles on the rise again, a KFF Health Misinformation Tracking Poll, fielded in late February, examines the extent to which adults have heard and believe misinformation about the measles vaccine. The poll also examines the public’s views of the U.S. government and social media companies’ role in moderating false health claims online. While most of the public—including parents—haven’t heard misinformation about the measles vaccine, many are uncertain…
Funding from CDC has been a major source of support for public health programs across the U.S., but CDC is now being targeted for budget cuts by the Trump administration. To better understand how much CDC funding is provided to state and local jurisdictions, we analyzed FY 2023 funding data from CDC and present findings about much funding was provided to state and local jurisdictions, what types of public health activities were supported with this…
Taken together, the new guidance on clinical trial requirements, the more restricted approval of the Novavax vaccine, and anticipated changes to CDC recommendations add up to fewer Americans eligible for COVID-19 vaccines and more limited access to these vaccines compared to previous years...such a shift would place the U.S. more in line with Australia, Canada, and countries in Europe.
© 2026 KFF